1. Introduction
1.1. Market Definition
1.2. Market Segmentation
2. Research Methodology
2.1. Research Data
2.2. Assumptions
3. Executive Summary
3.1. Research Highlights
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. The Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. Global Microneedle Drug Delivery Systems Market analysis, By Microneedle Type
5.1. Introduction
5.2. Hollow microneedle
5.3. Solid microneedle
5.4. Dissolving microneedle
5.5. Coated microneedle
5.6. Hydrogel-forming microneedle
6. Global Microneedle Drug Delivery Systems Market analysis, By Applications
6.1. Introduction
6.2. Neurologic Conditions
6.3. Cardiovascular
6.4. Dermatology
6.5. Others
7. Global Microneedle Drug Delivery Systems Market analysis, By Geography
7.1. Introduction
7.2. North America
7.3. South America
7.4. Europe
7.5. Middle East and Africa
7.6. Asia Pacific
8. Competitive Environment and Analysis
8.1. Major Players and Strategy Analysis
8.2. Emerging Players and Market Lucrativeness
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Vendor Competitiveness Matrix
9. Company Profiles
9.1. LTS Lohmann Therapie-Systeme AG
9.2. Nissha Co. Ltd.
9.3. ASTI Corporation
9.4. AdminMed nanoBioSciences LLC
9.5. Micron Biomedical Inc.
9.6. Raphas Co. Ltd.
9.7. Micropoint Technologies
9.8. 3M
9.9. MiNDERA Corporation
9.10. MyLife Technologies